Przemyslaw Zdziarski Andrzej Gamian
10.3389/fphar.2018.01559
Front Pharmacol
2019 Jan 18;9:1559.
foxp3+ regulatory t cells (treg) common variable immune deficiency (cvid) immune dysregulation lymphoid interstitial pneumonia (lip) lymphoproliferative disease (lpd) natural killer (nk) natural killer t-cells (nkt) rituximab, innate immune response
CC BY
https://pubmed.ncbi.nlm.nih.gov/30713498/
PMC6346143
30713498
Lymphoid Interstitial Pneumonia in Common Variable Immune Deficiency - Case Report With Disease Monitoring in Various Therapeutic Options: Pleiotropic Effects of Rituximab Regimens
2019